基于亨利定律的水中臭氧浓度检测方法研究

为提高水中臭氧(O_3)浓度检测方法的普适性、准确性和便捷性,提出了一种新的非接触式的水中O_3浓度检测方法。基于亨利定律(Henry’s Law),采用电化学方法,建立空气中O_3浓度与水中O_3浓度的回归方程,从而推导出水中O_3浓度。实验结果显示,水体O_3传感器的检出限为0.02 mg/L,检测上限为0.40 mg/L,可决系数R~2为0.998 9,相对误差最大值为7.05%,相对标准偏差最大值为2.82%。实际样品检测显示,水体O_3检测传感器的检测结果与O_3快速测定试剂盒(DPD法)的检测结果完全吻合。该方法不但综合了智能传感器的小型化、网络化、实时测量等特性,而且结构简单、成本低、响应快,适用于水体中O_3浓度的快速检测。     

家蝇AChE检测毒死蜱残留的最佳条件研究

以纯化的家蝇(Museadomestica)乙酰胆碱酯酶(AChE)为试验材料,研究了缓冲液pH值、底物(ATCh)浓度、温度三个因素对酶活性的影响。结果表明:在pH值为8.5￣9.0,温度为30℃,底物浓度为2.5mmol/L的条件下,该酶具有最大活性。在此基础上,测定了不同pH值的缓冲反应体系和不同抑制时间条件下毒死蜱(Chiorpyifos)对AChE活性的抑制,发现pH值为8.0时AChE对毒死蜱最为敏感,而且对毒死蜱具有良好的线性响应关系(R2=0.9973),半抑制浓度仅为39.1μg/(L抑制时间为20min),检测下限为4.4μg/L。随着抑制时间的延长,毒死蜱对AChE的抑制程度逐渐增强,检测限可进一步降低。可见家蝇AChE是指示环境中毒死蜱污染程度的良好材料。     

生物硝化池污水中硝化细菌的快速定量研究

实验采用聚合酶链式反应（PCR）技术与最大几率数法（MPN）相结合的MPN－PCR法对生物硝化池污水中的硝化细菌进行快速定量。所用的一对PCR引物是在对硝化细菌的16SrRNA基因进行系统比较的基础上设计合成的，可以扩增出大小为388bp的DNA片段。以从生物硝化池污水中抽提的含硝化细菌DNA的混合DNA为模板，进行PCR扩增并确定合适的扩增条件。运用MPN－PCR法进行定量检测的整个过程可在几小时之内完成。     

相关分析在大气优化布点过程中的成功演绎

通过相关指数在广东省城市大气环境监测省控站优化组筛选中的实践和探究,表明相关分析是个简单、实用、有效的方法,具有参考和应用价值。     

太湖流域水污染对太湖水质的影响分析

从太湖地区(苏州、无锡、常州、杭州、嘉兴和湖州)的污染物排放量、水质监测结果，以及工农业发展、人口变化、人民生活水平的提高、东太湖萎缩，底泥中营养物的变化和湖泊生态系统失衡的特点入手，分析了太湖流域水污染现状。结果表明，工业废水排放量高于城镇生活废水排放量；太湖湖体、环湖河流水质与省、市边界断面主要超标项目分别为：总磷、总氮和氨氮；水体水质演变是由工农业迅速发展、人口过度增加、污染防治措施相对滞后，以及太湖水生态系统失衡等原因造成的。     

脲酶抑制法检测环境样品中重金属离子研究

为探索利用脲酶快速检测环境样品中重金属离子的最佳条件，系统研究了重金属和缓冲液类型及其浓度对脲酶抑制率的影响。结果表明，不同浓度缓冲液中重金属离子浓度与脲酶抑制率呈显著的相关性，表现为随着重金属离子浓度的增加，脲酶抑制率也提高。缓冲液类型和浓度均能影响重金属对脲酶的抑制作用，其中磷酸缓冲液中，无论是Hg^2 还是Cu^2 对脲酶活性均有较强的抑制作用：在柠檬酸缓冲液中2种离子对脲酶的抑制作用存在显著差异。建立脲酶抑制检测技术的关键是选择合适的缓冲系统。此结果为脲酶抑制法在快速检测重金属离子中最佳检测条件的选择提供了理论依据。     

检测水中亚硫酸还原厌氧梭菌孢子的培养液富集法

水体中亚硫酸协还原菌的孢子，能在水中生存较长时间，容易在水池或管道中滋生，产生黑臭，可作为水体长期或周期性污染的一种指示，但目前国内尚无测定该菌的完整方法，作者建立了一种比较适合我国国情的测定方法，以国产蛋白陈替代胶胨型的水解液，结果阳性特征明显，精密度，重现性均较好。     

水中硫化物在线检测仪的研制

介绍硫离子在线检测仪的测定原理和基本系统结构,仪器采用流动注射法(FIA),具有测定周期短、试剂用量少的优点,该方法(显色剂为对二甲氨基苯胺)测定波长为665nm,工作范围ρ=2.0～25.0mg·L-1。回收率为96.1%～101.8%。     

Enhanced twin pregnancy detection within an open neural tube defect and down syndrome screening protocol using free-beta hCG and AFP

We have applied our multimarker approach of maternal serum alpha-fetoprotein (AFP) and free-beta human chorionic gonadotropin (hCG) for Down syndrome screening to multiple gestations to assess its efficacy for improved detection of twin and triplet pregnancies. This study matched 225 cases of twin pregnancy and 39 cases of triplet pregnancy each with ten singleton pregnancies based on gestational week, race, time to receive sample, time of year of sample, and geographical area. The ratios of the MOM for each group at the tenth, 50th, and 90th percentiles were compared by the Wilcoxon test. Risks for twins were calculated using Bayes' rule, the age-related incidence of twins, and the levels of AFP and free-beta hCG. The tenth, 50th, and 90th percentiles of free-beta hCG MOMs in twin and triplet cases were 0.85, 1.99, and 4.51, and 1.38, 2.78, and 4.07, respectively. For AFP, the MOMs at these percentiles were 1.26, 1.91, and 2.99, and 2.02, 2.68, and 5.30, respectively. The twin and triplet distributions for each marker were statistically significantly different from the singleton distributions (P<0.0001) and from each other (P=0.0012). At a twin risk cut-off of 1 in 50, 77.4 per cent of all twin gestations can be detected in a second-trimester AFP and free-beta hCG screening protocol with 5.1 per cent of singleton pregnancies falsely identified as at risk for twins. Our dual marker protocol for mid-trimester pregnancy screening combining AFP and free-beta hCG can identify over 77 per cent of twin pregnancies in women less than 35 years of age. This benefit may contribute to an improved outcome of pregnancy by early detection of multiple gestation.     

Use of the chemical cleavage of mismatch method for prenatal deficiency diagnosis of alpha-1-antitrypsin

The most common mutation in alpha-1-antitrypsin deficiency, conversion of a G to an A at base 9989 (PI-Z), was detected with the chemical cleavage of mismatch method, demonstrating the power of the method for prenatal diagnosis. Exon V of the gene was amplified using the polymerase chain reaction and heteroduplexes were formed to test for the presence of the mutation. The predicted C mismatch was readily detectable with hydroxylamine, and by making the probe from the chorionic villus sample it was possible to determine that the fetus was heterozygous, not homozygous, for the mutation.